France Veterinary Healthcare Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 4.00 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
France Veterinary Healthcare Market Analysis
The France Veterinary Healthcare Market is expected to witness a CAGR of 4% during the forecast period (2022-2027).
The Federation of Veterinarians of Europe in their July 2021 article indicated that the COVID-19 pandemic had greatly impacted the veterinary services in the European countries, including France, where only urgent and emergency treatment was allowed, which had a great impact on the loss of clients and revenue. The article also indicated that several veterinarians had suffered from physical and mental illness associated with the pandemic, isolation, financial restrictions, and the long-term effects of the infection. The restrictions imposed during the COVID-19 pandemic adversely affected the veterinary healthcare sector, with reductions in the number of diagnostic tests and treatments performed. Such reduction impacted the growth of the veterinary healthcare market.
Increasing demand to curb chronic and zoonotic diseases in livestock and pet animals is the key driver of this market. The global livestock population has been experiencing rapid growth over the past few decades. In developing countries like France, the demand for livestock products is increasing. Moreover, rising concerns about food security and animal husbandry are anticipated to boost demand for veterinary pharmaceuticals and vaccines for the livestock population in the forecast period.
In January 2022, following several occurrences of avian flu in France, the government ordered farmers to slaughter 2.5 million animals (H5N1). Since late November 2021, around 1.2 million birds have been slaughtered as a result of infection or as a preventative measure due to the disease's rapid spread. A large number of infections in the region require the need of proficient molecular diagnostics, which would add to the growth of the market in the forecast period.
The regional market is driven by technological advancements in veterinary health care, and this is anticipated to offer future growth opportunities. These advancements include the advent of efficient information management systems, animal owner mobile technology, and vaccine banks. A high focus on innovation in animal health has given rise to certain measures that are strengthening market growth prospects. For instance, the Innovative Medicines Initiative (IMI) is a public-private partnership to support collaborative research to boost innovation in veterinary pharmaceuticals in France.
Industry players are trying to develop innovative products such as mAbs and carrier drugs for better treatment outcomes. For instance, in November 2021, Fujifilm expanded into veterinary business with acquisition of French company DMV Imaging and launched FUJIFILM VET Systems France S.A.S.
Thus, due to the afore mentioned factors, the veterinary healthcare market in France is expected to grow significantly over the forecast period. However, lack of infrastructure and funding, use of counterfeit medicine and the rising cost of veterinary services are likely to hinder the market growth.
France Veterinary Healthcare Market Trends
This section covers the major market trends shaping the France Veterinary Healthcare Market according to our research experts:
Vaccines is expected to lead the France Veterinary Healthcare Market
The Vaccines segment in France's veterinary healthcare market is expected to register healthy growth during the forecast period due to the presence of good healthcare infrastructure in France and it is also experiencing positive trends in R&D developments. Inter-Governmental Organizations are making reforms to ensure health through the process of surveillance and vaccination. Also, awareness about pet health care and diagnostic techniques in the veterinary health care market will drive the market.
According to the estimates of the European Pet Food Industry: Facts and Figures 2020 (FEDIAF), there were around 7,500,000 dogs and 15,00,000 cats in France. The same source also reports that in France the small mammal population is 36,00,000.
In December 2020, the French government proposed new measures to fight pet abandonment such as an owner certificate and online charter. The document would explain the new owner's responsibilities and lay out expectations for the proper care of their new pet, including healthcare needs, vaccinations, the need to let the pet go outside, and the financial cost of care. This will create awareness among pet owners regarding their health, thus driving the veterinary healthcare market.
Hence, the market accounts for the high adoption of the pet population, thereby stimulating the demand for animal healthcare to control the prevalence of diseases. Therefore, all these factors are expected to drive the market in France.
France Veterinary Healthcare Industry Overview
The major players in the France Veterinary Healthcare Market include - Boehringer Ingelheim International GmbH, Ceva Animal Health, Inc., Elanco, IDEXX Laboratories, Merck & Co. Inc., Vetoquinol, and Zoetis Inc.
France Veterinary Healthcare Market Leaders
-
Elanco
-
Ceva Animal Health, Inc
-
Vetoquinol
-
Zoetis Inc.
-
Boehringer Ingelheim International GmbH
*Disclaimer: Major Players sorted in no particular order
France Veterinary Healthcare Market News
- In January 2022, TheraVet announced the signing of a distribution agreement for BIOCERA-VET-BS and BIOCERA-VET-OSA with one of the leading distributors of animal health products in France.
- Bactana Corp announced that they have signed a distribution agreement with France-based ArcaNatura SAS to launch Bactana's first commercial product, Pawsni Glucose Control, shown to significantly reduce diabetic and prediabetic blood markers in multiple placebo-controlled mouse trials without causing undesirable hypoglycemic side effects.
France Veterinary Healthcare Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare
- 4.2.2 Risk of Emerging Zoonosis
-
4.3 Market Restraints
- 4.3.1 Lack of Infrastructure and Funding
- 4.3.2 Use of Counterfeit Medicines
- 4.3.3 Increasing Costs of Animal Testing and Veterinary Services
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
-
5.1 By Product
- 5.1.1 By Therapeutics
- 5.1.1.1 Vaccines
- 5.1.1.2 Parasiticides
- 5.1.1.3 Anti-infectives
- 5.1.1.4 Medical Feed Additives
- 5.1.1.5 Other Therapeutics
- 5.1.2 By Diagnostics
- 5.1.2.1 Immunodiagnostic Tests
- 5.1.2.2 Molecular diagnostics
- 5.1.2.3 Diagnostic Imaging
- 5.1.2.4 Clinical Chemistry
- 5.1.2.5 Other Diagnostics
-
5.2 By Animal Type
- 5.2.1 Dogs and Cats
- 5.2.2 Horses
- 5.2.3 Ruminants
- 5.2.4 Swine
- 5.2.5 Poultry
- 5.2.6 Other Animals
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Boehringer Ingelheim International GmbH
- 6.1.2 Ceva Animal Health, Inc.
- 6.1.3 Elanco
- 6.1.4 IDEXX Laboratories
- 6.1.5 Merck & Co. Inc.
- 6.1.6 Vetoquinol
- 6.1.7 Zoetis Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityFrance Veterinary Healthcare Industry Segmentation
As per the scope of the report, Veterinary medicines are associated with treatment, diagnosis, and prevention of diseases among animals. It covers a variety of animal species, both, in domestic and wild. The France Veterinary Healthcare Market is segmented By Product (By Therapeutics, and By Diagnostics), and By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry and Other Animals). The report offers the value (in USD million) for the above segments.
| By Product | By Therapeutics | Vaccines |
| Parasiticides | ||
| Anti-infectives | ||
| Medical Feed Additives | ||
| Other Therapeutics | ||
| By Product | By Diagnostics | Immunodiagnostic Tests |
| Molecular diagnostics | ||
| Diagnostic Imaging | ||
| Clinical Chemistry | ||
| Other Diagnostics | ||
| By Animal Type | Dogs and Cats | |
| Horses | ||
| Ruminants | ||
| Swine | ||
| Poultry | ||
| Other Animals |
France Veterinary Healthcare Market Research FAQs
What is the current France Veterinary Healthcare Market size?
The France Veterinary Healthcare Market is projected to register a CAGR of 4% during the forecast period (2024-2029)
Who are the key players in France Veterinary Healthcare Market?
Elanco, Ceva Animal Health, Inc, Vetoquinol, Zoetis Inc. and Boehringer Ingelheim International GmbH are the major companies operating in the France Veterinary Healthcare Market.
What years does this France Veterinary Healthcare Market cover?
The report covers the France Veterinary Healthcare Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the France Veterinary Healthcare Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
France Veterinary Industry Report
Statistics for the 2024 France Veterinary market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Veterinary analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
